Shares of T. Rowe Price Capital Appreciation Equity ETF (NYSEARCA:TCAF – Get Free Report) hit a new 52-week high on Wednesday. The stock traded as high as $43.69 and last traded at $43.6670, with a volume of 206,139 shares traded. The stock had previously closed at $43.46.
T. Rowe Price Capital Appreciation Equity ETF Trading Up 0.5%
The stock has a market cap of $9.15 billion, a PE ratio of 29.44 and a beta of 0.94. The business has a 50-day moving average price of $42.74 and a 200-day moving average price of $41.12.
Hedge Funds Weigh In On T. Rowe Price Capital Appreciation Equity ETF
A number of large investors have recently added to or reduced their stakes in TCAF. Geneos Wealth Management Inc. lifted its stake in T. Rowe Price Capital Appreciation Equity ETF by 36.9% in the 1st quarter. Geneos Wealth Management Inc. now owns 3,155 shares of the company’s stock worth $112,000 after purchasing an additional 850 shares in the last quarter. Continuum Advisory LLC acquired a new position in shares of T. Rowe Price Capital Appreciation Equity ETF during the 2nd quarter worth approximately $197,000. Brookstone Capital Management acquired a new position in shares of T. Rowe Price Capital Appreciation Equity ETF during the 1st quarter worth approximately $205,000. RFG Advisory LLC purchased a new stake in shares of T. Rowe Price Capital Appreciation Equity ETF in the first quarter valued at approximately $214,000. Finally, Prosperity Consulting Group LLC grew its position in shares of T. Rowe Price Capital Appreciation Equity ETF by 8.1% in the first quarter. Prosperity Consulting Group LLC now owns 6,126 shares of the company’s stock valued at $218,000 after purchasing an additional 457 shares in the last quarter.
T. Rowe Price Capital Appreciation Equity ETF Company Profile
The T. Rowe Price Capital Appreciation Equity ETF (TCAF) is an exchange-traded fund. The fund’s investment portfolio concentrates primarily on large cap equity. TCAF is an actively managed fund that pursues higher quality stocks of US large-cap companies that are perceived to have above average potential for capital growth.
Read More
- Five stocks we like better than T. Rowe Price Capital Appreciation Equity ETF
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
- Synchrony Aces The Quarter As Credit Fears Fade
- Higher Rates Are Sending Investors to These 3 Dividend Kings
Receive News & Ratings for T. Rowe Price Capital Appreciation Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T. Rowe Price Capital Appreciation Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
